Donn M. Dennis
Corporate Officer/Principal bij University of Florida
Profiel
Dr. Donn M.
Dennis, MD, is Chief Scientific Officer at Xhale, Inc., Co-Founder at NanoMedex Pharmaceuticals, Inc., a Professor at University of Florida, and a Principal at Kegonsa Capital Partners LLC.
Dr. Dennis was previously employed as Vice President-Pharmacology by ARYx Therapeutics, Inc.
He received his undergraduate degree from Michigan Technological University and a doctorate degree from the University of Michigan.
Actieve functies van Donn M. Dennis
| Bedrijven | Functie | Begin |
|---|---|---|
| University of Florida | Corporate Officer/Principal | 26-06-2009 |
Eerdere bekende functies van Donn M. Dennis
| Bedrijven | Functie | Einde |
|---|---|---|
Xhale, Inc.
 Xhale, Inc. Medical SpecialtiesHealth Technology Xhale, Inc. operates as a medical technology company. It develops and commercializes patient-centric monitoring solutions for the healthcare industry. The firm specializes in biotechnology, medical devices, clinical trials monitoring, and breath diagnostics. The company was founded by Richard J. Melker and Donn M. Dennis in 2005 and is headquartered in Gainesville, FL. | Oprichter | - |
NanoMedex Pharmaceuticals, Inc.
 NanoMedex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NanoMedex Pharmaceuticals, Inc. develops formulation strategy to allow drugs that are only soluble in oil to be soluble in water. It offers offers Microfol, a micro emulsion formulation containing the generic active pharmaceutical ingredient propofol and two IIG listed excipients-sodium caprylate and poloxamer, which replaces the macro emulsion components of the reference listed drug and its generic equivalents. The company’s formulation is applied to drug classes, including chemotherapeutics, anesthetics, anti-infective, anti-inflammatories and arrythmics, immunosuppressants, and vitamins. NanoMedex Pharmaceuticals was founded by Donn M. Dennis, Nikolaus Gravenstein, Jerome H. Modell and Timothy E. Morey in 2002 and is headquartered in Middleton, WI. | Oprichter | - |
| ARYX THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Opleiding van Donn M. Dennis
| Michigan Technological University | Undergraduate Degree |
| University of Michigan | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ARYX THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Xhale, Inc.
Xhale, Inc. Medical SpecialtiesHealth Technology Xhale, Inc. operates as a medical technology company. It develops and commercializes patient-centric monitoring solutions for the healthcare industry. The firm specializes in biotechnology, medical devices, clinical trials monitoring, and breath diagnostics. The company was founded by Richard J. Melker and Donn M. Dennis in 2005 and is headquartered in Gainesville, FL. | Health Technology |
NanoMedex Pharmaceuticals, Inc.
NanoMedex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NanoMedex Pharmaceuticals, Inc. develops formulation strategy to allow drugs that are only soluble in oil to be soluble in water. It offers offers Microfol, a micro emulsion formulation containing the generic active pharmaceutical ingredient propofol and two IIG listed excipients-sodium caprylate and poloxamer, which replaces the macro emulsion components of the reference listed drug and its generic equivalents. The company’s formulation is applied to drug classes, including chemotherapeutics, anesthetics, anti-infective, anti-inflammatories and arrythmics, immunosuppressants, and vitamins. NanoMedex Pharmaceuticals was founded by Donn M. Dennis, Nikolaus Gravenstein, Jerome H. Modell and Timothy E. Morey in 2002 and is headquartered in Middleton, WI. | Health Technology |
